Law Firm Opens Investigation Into Ardent Health's $97M Accounting Adjustments

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Law firm Hagens Berman investigates Ardent Health for securities fraud over $97M accounting adjustments. Stock fell 33% after November disclosure of revenue revisions and reserve increases.

Law Firm Opens Investigation Into Ardent Health's $97M Accounting Adjustments

Hagens Berman has initiated an investigation into securities fraud claims against Ardent Health Services, Inc. (ARDT) regarding significant accounting adjustments revealed in November 2025. The healthcare company disclosed a $42.6 million revenue adjustment coupled with a $54 million increase in professional liability reserves, totaling approximately $97 million in restatements. The adjustments reportedly stem from a shift in the company's methodology for accounting for uncollectible accounts, moving to what plaintiffs characterize as a rigid 180-day cliff approach.

According to the investigation notice, Ardent Health's revised accounting method represents a departure from prior disclosures indicating the company conducted detailed historical reviews to determine reserve adequacy. The abrupt shift in approach and magnitude of the adjustments raised questions about whether previous financial statements adequately reflected the company's true financial position. The market responded sharply to the announcement, with ARDT shares declining approximately 33% from their pre-disclosure levels.

Investors who purchased Ardent Health securities during the relevant period and wish to participate in the investigation have until March 9, 2026, to establish their status as lead plaintiffs. The investigation examines whether company leadership failed to disclose material information regarding accounting practices and the financial impact of the methodological change prior to November 2025.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 16

Related Coverage

GlobeNewswire Inc.

Graphic Packaging Hit With Securities Class Action Over Misleading Statements

Rosen Law Firm files securities class action against $GPK, alleging false statements on financial performance and operations. Investors may pursue compensation.

GPKSMCITCOM
GlobeNewswire Inc.

Trip.com Investors Face May 11 Deadline in Securities Fraud Class Action

Rosen Law Firm urges TCOM investors to act before May 11, 2026 deadline in securities class action alleging false statements about regulatory risks.

TCOM
GlobeNewswire Inc.

Primoris Stock Plummets 50% as Renewables Crisis Exposes Systemic Project Failures

$PRIM shares collapsed 50% after revealing widespread solar project execution issues. Massive revenue and margin declines contradicted prior management guidance.

PRIM
GlobeNewswire Inc.

Super Micro Computer Faces Major Securities Class Action Over Undisclosed China Sales

Rosen Law Firm urges Super Micro Computer investors to join class action lawsuit alleging undisclosed China sales and export control violations through March 2026 deadline.

SMCI
GlobeNewswire Inc.

Upstart Investors Face June 2026 Deadline in Securities Class Action Over Faulty AI Model

Law firm Kirby McInerney LLP reminds Upstart investors of June 8, 2026 deadline to join securities lawsuit alleging the company's Model 22 AI overstated accuracy and loan approvals.

UPST
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF